For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
29 September 2022
Mary Elizabeth Stern and Lucy Allen
In their fourteenth annual review of asbestos-related liabilities reported in companies’ 10-Ks, NERA Director Mary Elizabeth C. Stern and Managing Director Lucy P. Allen use publicly available data to analyze trends in asbestos-related liabilities spanning from 2008 to 2021.
Highlights from this report included:
In addition to reviewing 10-Ks, the authors collect data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program on the incidence of mesothelioma diagnoses in the United States. The authors found after falling 14% over the 2016–2018 period and reaching its lowest level since 2010, mesothelioma incidence increased 6% in 2019 (the most recent data available).
Please contact the authors if you would like NERA to analyze your asbestos data in conjunction with that of other public companies in a benchmarking study.